News
American multinational Amgen has teamed up with the Lazarex Cancer Foundation in support of an initiative aimed at increasing access to clinical...
The atopic dermatitis (eczema) market is expected to reach $18.3 billion by 2027, according to analytics firm GlobalData.
Clinical stage oncology firm Oxford BioTherapeutics has signed a deal with the open-access biologics technology platform company WuXi Biologics, in...
A digital therapeutic launched by Pear Therapeutics and Novartis’ generics and biosimilars division Sandoz has become the first FDA-approved app of...
Pfizer’s palbociclib is the most commonly used breast cancer drug in clinical trials, according to analytics firm GlobalData.
Boehringer Ingelheim is set to follow in the recent steps of Sanofi with the announcement of a cull of over 300 employees in France – around 10% of...
Tanzania has become the first country in Africa to achieve a well-functioning regulatory system for medical products, according to the World Health...
At least 16 generic drugmakers are being investigated for their involvement in what has been described as the “largest cartel in the history of the...
AstraZeneca is to team up with Cancer Research UK to build a new centre of excellence for accelerating the discovery and development of new cancer...
